OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech FTFT Q2 2024 Earnings Narrowing Losses Amidst Strategic Transformation in Blockchain and Fintech OXLCZ Q4 2025 Earnings EPS Misses Estimates Despite Steady Performance HTCR Q2 2025 Earnings EPS Surges Past Estimates Driving Stock Rally IMAX Q1 2026 Earnings Earnings Per Share Surpasses Estimates by 98 GLXY Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Climbs 648 Despite Disappointment